Skip to main content
Log in

Use of ivabradine in catecholamine-induced tachycardia after high-risk cardiac surgery

  • Letter to the Editors
  • Published:
Clinical Research in Cardiology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. St André AC, Del Rossi A (2005) Hemodynamic management of patients in the first 24 hours after cardiac surgery. Crit Care Med 33:2082–2093

    Article  Google Scholar 

  2. Fellahi JL, Parienti JJ, Hanouz JL, Plaud B, Riou B, Ouattara A (2008) Perioperative use of dobutamine in cardiac surgery and adverse cardiac outcome: propensity-adjusted analyses. Anesthesiology 108:979–987

    Article  CAS  PubMed  Google Scholar 

  3. DiFrancesco D (2010) The role of the funny current in pacemaker activity. Circ Res 106:434–446

    Article  CAS  PubMed  Google Scholar 

  4. Fox K, Ford I, Steg PG, Tendera M, Ferrari R, BEAUTIFUL Investigators (2008) Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial. Lancet 372:807–816

    Article  CAS  PubMed  Google Scholar 

  5. Fox K, Ford I, Steg PG, Tendera M, Robertson M, Ferrari R, BEAUTIFUL investigators (2008) Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial. Lancet 372:817–821

    Article  PubMed  Google Scholar 

  6. Singer JD, Willett JB (2003) Applied longitudinal data analysis: modeling change and event occurrence. Oxford University Press, New York

    Google Scholar 

  7. Diggle PJ, Liang KY, Zeger SL (1994) Analysis of longitudinal data. Oxford University Press, Oxford

    Google Scholar 

  8. Bollano E, Täng MS, Hjalmarson A, Waagstein F, Andersson B (2003) Different responses to dobutamine in the presence of carvedilol or metoprolol in patients with chronic heart failure. Heart 89:621–624

    Article  CAS  PubMed  Google Scholar 

  9. Tarnow J, Komar K (1988) Altered hemodynamic response to dobutamine in relation to the degree of preoperative beta-adrenoceptor blockade. Anesthesiology 68:912–919

    Article  CAS  PubMed  Google Scholar 

  10. Vatner SF, McRitchie RJ, Braunwald E (1974) Effects of dobutamine on left ventricular performance, coronary dynamics, and distribution of cardiac output in conscious dogs. J Clin Invest 53:1265–1273

    Article  CAS  PubMed  Google Scholar 

  11. Link A, Reil JC, Selejan S, Böhm M (2009) Effect of ivabradine in dobutamine induced sinus tachycardia in a case of acute heart failure. Clin Res Cardiol 98:513–515

    Article  PubMed  Google Scholar 

  12. Monnet X, Ghaleh B, Colin P, de Curzon OP, Giudicelli JF, Berdeaux A (2001) Effects of heart rate reduction with ivabradine on exercise-induced myocardial ischemia and stunning. J Pharmacol Exp Ther 299:1133–1139

    CAS  PubMed  Google Scholar 

  13. Romson JL, Leung JM, Bellows WH et al (1999) Effects of dobutamine on hemodynamics and left ventricular performance after cardiopulmonary bypass in cardiac surgical patients. Anesthesiology 91:1318–1328

    Article  CAS  PubMed  Google Scholar 

  14. Mythen MG (2005) Postoperative gastrointestinal tract dysfunction. Anesth Analg 100:196–204

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This study was funded by an independent research Grant from the Department of Anesthesiology and Intensive Care of the “Sapienza” University of Rome.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Vincenzo De Santis.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vitale, D., De Santis, V., Guarracino, F. et al. Use of ivabradine in catecholamine-induced tachycardia after high-risk cardiac surgery. Clin Res Cardiol 99, 853–855 (2010). https://doi.org/10.1007/s00392-010-0208-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00392-010-0208-9

Keywords

Navigation